Kazuya Takamochi Selected Research

Kazuya Takamochi Research Topics

Disease

37	Neoplasms (Cancer) 10/2022 - 05/2004
29	Lung Neoplasms (Lung Cancer) 03/2022 - 09/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 02/2005
18	Adenocarcinoma of Lung 03/2022 - 10/2007
9	Adenocarcinoma 09/2020 - 12/2003
5	Fistula 10/2022 - 10/2019
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2010
4	Lymphatic Metastasis 03/2021 - 01/2013
3	Atrial Fibrillation 02/2019 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2017 - 08/2008
2	Thrombosis (Thrombus) 10/2022 - 02/2019
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2021 - 06/2021
2	Disease Progression 03/2021 - 01/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021 - 11/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2020 - 03/2017
2	Microsatellite Instability 04/2019 - 01/2017
2	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 12/2016 - 10/2015
2	Chylothorax 02/2016 - 09/2002
1	Hemoptysis 10/2022
1	Wounds and Injuries (Trauma) 08/2022
1	Pain (Aches) 08/2022
1	Cardiac Arrhythmias (Arrythmia) 12/2021
1	Mesothelioma 08/2021
1	Malignant Mesothelioma 08/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020
1	Necrosis 01/2020
1	Embolism (Embolus) 02/2019
1	Diabetes Mellitus 02/2019
1	Giant Cell Tumors (Giant Cell Tumor) 01/2019
1	Infections 05/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

10	Carcinoembryonic AntigenIBA 11/2021 - 05/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2007
7	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2007
4	Proteins (Proteins, Gene)FDA Link 07/2021 - 11/2008
4	Gefitinib (Iressa)FDA Link 11/2019 - 10/2007
3	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 12/2004
2	osimertinibIBA 01/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2010
2	MucinsIBA 08/2021 - 01/2021
2	Thyroid Nuclear Factor 1IBA 07/2021 - 06/2021
2	Protein Isoforms (Isoforms)IBA 07/2021 - 03/2017
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
2	GlypicansIBA 09/2020 - 01/2018
2	Transcription Factor 4IBA 11/2019 - 01/2018
2	ParaffinIBA 04/2019 - 08/2008
2	AnticoagulantsIBA 02/2019 - 02/2019
2	Carbon MonoxideIBA 01/2019 - 05/2011
2	Thymidylate SynthaseIBA 09/2017 - 01/2015
2	Galectin 4 (LGALS4)IBA 09/2017 - 01/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2017 - 08/2008
2	Messenger RNA (mRNA)IBA 01/2017 - 03/2010
2	polyacrylamideIBA 01/2013 - 11/2008
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	AfatinibIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	PlatinumIBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	B7-H1 AntigenIBA 11/2021
1	AsbestosIBA 08/2021
1	Alcian BlueIBA 08/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	SteroidsIBA 03/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021
1	NivolumabIBA 01/2021
1	IntegrinsIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2020
1	nintedanibIBA 07/2020
1	Insulin (Novolin)FDA Link 01/2020
1	vasectrin I (VS I)IBA 06/2019
1	Formaldehyde (Formol)FDA Link 04/2019
1	NucleotidesIBA 04/2019
1	Warfarin (Coumadin)FDA LinkGeneric 02/2019
1	TegafurIBA 01/2019
1	UracilIBA 01/2019
1	Denosumab FDA Link 01/2019
1	GlycogenIBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Fetal Proteins (Fetoprotein)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 09/2017
1	sivelestatIBA 06/2017

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2007
12	Segmental Mastectomy (Lumpectomy) 04/2021 - 03/2011
6	Pneumonectomy (Lung Volume Reduction) 11/2022 - 12/2003
6	Radiotherapy 01/2022 - 12/2016
6	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 09/2002
5	Drug Therapy (Chemotherapy) 01/2019 - 10/2007
4	Chemoradiotherapy 10/2022 - 12/2016
4	Adjuvant Chemotherapy 05/2022 - 04/2010
3	Immunotherapy 01/2022 - 01/2021
3	Precision Medicine 06/2021 - 09/2016
2	Thoracotomy 08/2022 - 06/2015
2	Operative Surgical Procedures 01/2021 - 02/2019
2	Chest Tubes (Chest Tube) 02/2016 - 09/2002
1	Induction Chemotherapy 01/2022
1	Combined Modality Therapy 03/2021
1	Critical Care (Surgical Intensive Care) 01/2020
1	Palliative Care (Palliative Therapy) 05/2018